Published in J Proteome Res on August 18, 2007
Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol (2010) 2.55
Current mathematical methods used in QSAR/QSPR studies. Int J Mol Sci (2009) 0.90
Serum metabonomic analysis of protective effects of Curcuma aromatica oil on renal fibrosis rats. PLoS One (2014) 0.79
Knowledge discovery in spectral data by means of complex networks. Metabolites (2013) 0.79
Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease. Oncotarget (2016) 0.78
Effect of High-Carbohydrate Diet on Plasma Metabolome in Mice with Mitochondrial Respiratory Chain Complex III Deficiency. Int J Mol Sci (2016) 0.75
Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease. Redox Biol (2017) 0.75
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics. Diseases (2016) 0.75
Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int (2004) 2.30
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J (2004) 2.09
Inhibition of the renin-angiotensin system and chronic kidney disease. Int Urol Nephrol (2008) 1.50
Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment. Am J Nephrol (2008) 1.46
Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis (2006) 1.44
Sevelamer hydrochloride versus aluminum hydroxide: effect on serum phosphorus and lipids in CAPD patients. Perit Dial Int (2006) 1.42
Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine. Thyroid (2003) 1.40
Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed (2008) 1.25
LDL cholesterol estimation in patients with the metabolic syndrome. Lipids Health Dis (2006) 1.12
Evaluation of methods for the measurement of low-density lipoprotein cholesterol. J Cardiovasc Pharmacol Ther (2005) 1.05
Lipid profile, glucose homeostasis, blood pressure, and obesity-anthropometric markers in macrosomic offspring of nondiabetic mothers. Diabetes Care (2006) 1.01
Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure. Eur J Heart Fail (2002) 0.97
Zosteriform cutaneous metastases from breast adenocarcinoma. J Eur Acad Dermatol Venereol (2005) 0.95
Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals. Int J Cardiol (2005) 0.95
Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial. J Hypertens (2006) 0.94
Evaluation of alternative calculation methods for determining low-density lipoprotein cholesterol in hemodialysis patients. Clin Biochem (2004) 0.94
C.E.R.A. once every 4 weeks in patients with chronic kidney disease not on dialysis: The ARCTOS extension study. Hemodial Int (2009) 0.93
The role of obesity in kidney disease: recent findings and potential mechanisms. Int Urol Nephrol (2011) 0.92
A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia. Clin Ther (2007) 0.92
Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance. Cardiovasc Drugs Ther (2007) 0.91
Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease. Am J Nephrol (2012) 0.89
Pathophysiology and management of fluid and electrolyte disturbances in patients on chronic dialysis with severe hyperglycemia. Semin Dial (2008) 0.89
Effects of rosuvastatin with or without ezetimibe on clinical outcomes in patients undergoing elective vascular surgery: results of a pilot study. J Cardiovasc Pharmacol Ther (2012) 0.88
Influence of apolipoprotein E polymorphisms on serum creatinine levels and predicted glomerular filtration rate in healthy subjects. Nephrol Dial Transplant (2004) 0.85
Defensive coping and health-related quality of life in chronic kidney disease: a cross-sectional study. BMC Nephrol (2011) 0.85
Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis. Perit Dial Int (2004) 0.83
Novel therapies of diabetic nephropathy. Curr Opin Nephrol Hypertens (2009) 0.83
PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin. Nephrol Dial Transplant (2006) 0.83
Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia. J Cardiovasc Pharmacol Ther (2009) 0.83
Efficacy of aliskiren and valsartan in hypertensive patients with albuminuria: a randomized parallel-group study. J Renin Angiotensin Aldosterone Syst (2012) 0.82
Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Am J Nephrol (2007) 0.82
Hypouricemia in individuals admitted to an inpatient hospital-based facility. Am J Kidney Dis (2003) 0.81
Prothrombotic state, cardiovascular, and metabolic syndrome risk factors in prepubertal children born large for gestational age. Diabetes Care (2010) 0.81
Body fluid abnormalities in severe hyperglycemia in patients on chronic dialysis: review of published reports. J Diabetes Complications (2008) 0.80
Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration. Artif Organs (2003) 0.80
Dose-dependent effect of rosuvastatin treatment on urinary protein excretion. J Cardiovasc Pharmacol Ther (2007) 0.80
Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: a unique clinical/physiologic exercise in internal potassium balance. Int Urol Nephrol (2010) 0.80
Serum potassium concentration in hyperglycemia of chronic dialysis. Adv Perit Dial (2005) 0.79
Differential membrane expression of Toll-like receptors and intracellular cytokine induction in peripheral blood monocytes of patients with chronic kidney disease and diabetic nephropathy. Nephron Clin Pract (2015) 0.79
Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: effect of long-term therapy with erythropoietin. Kidney Int (2005) 0.79
Risk factors for cognitive dysfunction in CKD and hypertensive subjects. Int Urol Nephrol (2013) 0.79
Analysis of 6-month effect of orlistat administration, alone or in combination with fenofibrate, on triglyceride-rich lipoprotein metabolism in overweight and obese patients with metabolic syndrome. J Clin Lipidol (2008) 0.79
The influence of serum apolipoprotein E concentration and polymorphism on serum lipid parameters in hemodialysis patients. Am J Kidney Dis (2004) 0.79
Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjects. J Stroke Cerebrovasc Dis (2010) 0.78
The QUEST initiative anemia study in ESRD: rationale and study protocol. J Nephrol (2007) 0.78
Role of the dialyzer membrane on the overall phosphate kinetics during hemodialysis. Blood Purif (2005) 0.78
The QUEST initiative anemia study in transplant patients: rationale and study protocol. J Nephrol (2007) 0.78
Posterior reversible encephalopathy syndrome: a noteworthy syndrome in end-stage renal disease patients. Nephron Clin Pract (2013) 0.78
Vitamin D, parathormone, and insulin resistance in children born large for gestational age. J Pediatr Endocrinol Metab (2014) 0.77
Switch from conventional to every other day hemodialysis: a comparison pilot study. ASAIO J (2009) 0.77
Acid-base and electrolyte disturbances in patients with hypercalcemia. South Med J (2002) 0.77
Acute effect of heparin on lipid parameters in patients on renal replacement therapy. ASAIO J (2007) 0.77
Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome. J Renin Angiotensin Aldosterone Syst (2007) 0.77
Tyrosine nitration in plasma proteins from patients undergoing hemodialysis. Am J Kidney Dis (2004) 0.77
Longitudinal association of body mass index and waist circumference with left ventricular mass in hypertensive predialysis chronic kidney disease patients. Nephrol Dial Transplant (2013) 0.77
Environmental and stressful factors affecting the occurrence of kidney stones and the kidney colic. Int Urol Nephrol (2014) 0.77
Optimal medical management in patients with renovascular hypertension. Am J Cardiovasc Drugs (2013) 0.76
Body fluid abnormalities in severe hyperglycemia in patients on chronic dialysis: theoretical analysis. J Diabetes Complications (2007) 0.76
Influence of the type of membrane and heparin on serum lipid parameters during a dialysis session: a pilot study. Am J Nephrol (2004) 0.76
Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals. Atherosclerosis (2005) 0.76
Visceral leishmaniasis is associated with marked changes in serum lipid profile. Eur J Clin Invest (2014) 0.76
Renal sympathetic denervation and renal physiology. Curr Clin Pharmacol (2013) 0.76
Flow cytometric estimation of 'labile iron pool' in human white blood cells reveals a positive association with ageing. Free Radic Res (2008) 0.76
Evaluation of established coronary heart disease on the basis of HDL and non-HDL NMR lipid profiling. J Proteome Res (2010) 0.76
Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemia. J Clin Pharmacol (2006) 0.76
NMR-based lipidomic analysis of blood lipoproteins differentiates the progression of coronary heart disease. J Proteome Res (2014) 0.76
Evaluation of the proximal tubular function in individuals with primary renal hypouricemia: an NMR-based metabonomic study. NMR Biomed (2009) 0.75
Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: review of published reports. Int Urol Nephrol (2010) 0.75
Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients. Nephron Clin Pract (2009) 0.75
Aliskiren in an alternate-day administration schedule in hypertensive albuminuric patients. Blood Press Monit (2014) 0.75
Urine of patients with nephrotic syndrome contains the plasma type of PAF-acetylhydrolase associated with lipoproteins. Nephron Physiol (2004) 0.75
A patient with new-onset hypercholesterolemia. J Clin Lipidol (2009) 0.75
Phantom cytomegalovirus infection in vasculitis patients: what it means and what to do. Rheumatol Int (2004) 0.75
Should targeting albuminuria be part of a cardiovascular risk reduction paradigm? Cardiol Clin (2010) 0.75